Prolactin is a pituitary hormone best known for enabling milk production during and after pregnancy, but it has broader roles in immune function, metabolism, and reproductive health. Levels fluctuate with stress, sleep, and sexual activity, so timing of measurement matters.
Elevated prolactin (hyperprolactinemia) suppresses reproductive hormones and can cause infertility, low libido, and irregular periods in women or erectile dysfunction and low testosterone in men. Causes range from medication side effects to pituitary tumors (prolactinomas), and meaningfully elevated levels warrant investigation. Mildly elevated prolactin is often stress-related and resolves spontaneously. For nursing mothers or recently pregnant women, elevated prolactin is expected and appropriate.
Optimal Prolactin: 2-15 ng/mL.
Typically re-tested every 10 weeks.
It is measured from a standard blood draw, most often as part of a hormone panel. Because the hormone responds to sleep, stress, exercise and nipple stimulation, one elevated value is a starting point rather than an answer. Context and a repeat sample do most of the interpretive work.
Prolactin is a protein hormone released by lactotroph cells in the anterior pituitary gland that stimulates breast milk production and influences reproductive, metabolic and immune signalling throughout the body.
It behaves differently from most pituitary hormones. Rather than waiting for a release signal, lactotrophs secrete continuously and the hypothalamus holds them back using dopamine. Anything that reduces dopamine reaching the pituitary, whether a medication that blocks dopamine receptors or a physical interruption of the pituitary stalk, tends to lift the circulating level. Thyrotropin-releasing hormone and oestrogen push in the opposite direction and stimulate release.
Secretion is pulsatile and follows a daily rhythm, running highest during sleep and in the hours just after waking, then drifting down across the morning, which is one reason laboratory guidance emphasises standardised sampling conditions[1]. Receptors sit in breast tissue, the ovaries and testes, the liver, the brain and immune cells, which is why the hormone has effects well beyond lactation.
One more detail matters for reading results. Prolactin circulates in more than one molecular form. The small monomeric form is biologically active, while larger complexes, collectively called macroprolactin, are mostly inactive yet still register on many assays[2].
It matters because a sustained elevation suppresses the reproductive hormone axis, and that suppression has knock-on effects on fertility, libido, cycle regularity and bone.
The mechanism is straightforward. High prolactin dampens the pulsed release of gonadotropin-releasing hormone from the hypothalamus. Luteinising hormone and follicle-stimulating hormone fall in response, and testosterone or oestradiol fall after them. Clinical practice guidance describes the resulting picture of hypogonadism, irregular or absent periods, galactorrhoea and reduced fertility as the core consequences of sustained hyperprolactinaemia[3]. Left unaddressed over years, low sex hormones are associated with reduced bone mineral density, which is part of why clinicians take a persistent elevation seriously rather than waiting it out.
The marker is also a window into pituitary function generally. After head injury, prolactin is one of the pituitary outputs that can shift, and research suggests it carries information about hypothalamic-pituitary disruption in that setting[4]. In people with childhood-onset craniopharyngioma, serum concentrations have been studied as a reflection of hypothalamic and pituitary involvement[5].
Beyond reproduction, prolactin has immune-modulating activity. Research has examined its role in multiple sclerosis, where the hormone appears to interact with both inflammatory and repair processes[6]. Studies indicate links with endometriosis too, both in pain signalling[7] and in endometriosis-associated infertility[8]. None of that makes prolactin a standalone screening test for those conditions, but it does explain why it earns a place on a hormone panel rather than sitting in a lactation-only corner.
Most laboratories regard roughly 2 to 25 ng/mL as the typical adult reference range, while FitScript's optimal range is tighter for the general adult population and matches the standard range for women.
| Group | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Adults, general | 2 to 25 ng/mL | 2 to 15 ng/mL |
| Women | 2 to 30 ng/mL | 2 to 25 ng/mL |
Healthy adults in Münster, Germany, were studied: 220 men aged 20 to 68, 226 women aged 25 to 44 sampled in either the follicular or luteal phase, and 103 postmenopausal women aged 49 to 66. Premenopausal women had much higher upper limits than men or postmenopausal women.[13]
| Sex | Age | Reference range (ng/mL) |
|---|---|---|
| Men | 20 to 68 | 2.73 to 15.1 |
| Women | 25 to 44 (follicular phase) | 3.88 to 40.1 |
| Women | 25 to 44 (luteal phase) | 4.65 to 50.9 |
| Women | 49 to 66 (postmenopausal) | 2.64 to 11.6 |
Intervals are 2.5th to 97.5th percentiles on the Siemens Advia Centaur platform, split by sex and menstrual status; prolactin results differ notably between assays. Your own lab's printed range is the one to read your result against.
Reference ranges vary by laboratory, age and sex, and by the assay platform used, so always read your result against the range printed on your own report. FitScript's optimal ranges are optimisation targets, not diagnostic cut-offs, and a value outside them is a prompt for conversation rather than a verdict.
Two practical notes. Units differ between labs. Results may appear as ng/mL, as µg/L, which is numerically identical, or as mIU/L, which uses a different scale entirely, so converting before comparing two reports is essential. And pregnancy and breastfeeding raise prolactin substantially by design. Values during those periods are interpreted against a different frame of reference and are not compared with the ranges above.
An elevated result means more prolactin was circulating at the moment of the draw, which can reflect something as ordinary as the timing of the sample or as specific as a medication effect or a pituitary finding. It is not a diagnosis on its own.
People with persistently raised levels commonly report irregular, light or absent periods, reduced libido, difficulty conceiving, erectile difficulty, unexpected nipple discharge and sometimes low mood or fatigue. When a pituitary mass is involved, headaches or changes in peripheral vision can appear alongside the hormonal picture. Many people with mildly raised values report nothing at all, which is part of why the marker is so often found incidentally on a panel.
The common explanations fall into a few groups. Physiological causes include sleep, recent meals, intense exercise, sexual activity, nipple or chest wall stimulation, and the stress of the venepuncture itself. Medication effects are the most frequent non-physiological cause in practice, with dopamine-blocking medicines used in psychiatric care the clearest example. A systematic review and dose-response meta-analysis found that prolactin elevation with these medicines differs markedly between agents and relates to dose[9], and elevated levels are a well-described finding among people receiving psychiatric care[10]. Where management is needed, a network meta-analysis has compared pharmacological strategies for antipsychotic-induced hyperprolactinaemia, and any such decision is one a licensed provider makes after reviewing the whole clinical picture[11]. Other recognised contributors include underactive thyroid, chronic kidney or liver disease, pituitary adenoma, and prior head injury[4].
The long-term significance depends entirely on the cause and on whether the elevation persists. Sustained suppression of sex hormones is the main concern, with fertility and bone density the usual focus. Clinical guidance recommends confirming a raised value and investigating systematically rather than acting on a single number[3]. A markedly high result, or one accompanied by vision changes or headaches, is worth discussing with a clinician promptly.
A low result usually means little on its own, because there is no meaningful lower limit of concern for most adults outside the postpartum period, and many laboratories report the bottom of the range as simply undetectable rather than abnormal.
The symptom most clearly tied to genuinely deficient prolactin is difficulty establishing or maintaining milk supply after birth. Outside that context, people with low values typically report nothing attributable to the hormone itself, and any symptoms present usually trace back to whatever else is happening in the pituitary.
When a low value does carry information, it tends to be as part of a broader picture of reduced pituitary output. Damage to the gland or its stalk from surgery, radiotherapy, severe postpartum haemorrhage or traumatic brain injury can lower several pituitary hormones together[4], and in people with childhood-onset craniopharyngioma, concentrations have been examined in relation to hypothalamic and pituitary damage[5]. Medicines that act on dopamine pathways also lower the level, which is their intended pharmacological effect.
In terms of long-term health, an isolated low prolactin with normal thyroid, gonadal and adrenal markers is rarely pursued. A low value sitting alongside low LH, low FSH, low TSH or low morning cortisol is a different pattern, and that combination is worth reviewing with a clinician rather than interpreting marker by marker.
Quite a lot can shift it, which is why laboratories pay unusual attention to how the sample is taken and why a repeat draw is standard before anything is concluded.
Testing conditions come first. Because secretion peaks during sleep and declines through the morning, samples drawn soon after waking tend to read higher than mid-morning ones. Venepuncture stress, a long fast, a hard training session, sexual activity and nipple or chest wall stimulation in the hours beforehand can all nudge the value upward, and laboratory guidance highlights standardised collection as central to a usable result[1]. A calm, rested, mid-morning draw is the usual compromise.
Medications are the second major influence. Dopamine-blocking antipsychotics are the best-documented group, with effects that vary by agent and by dose[9]. No medication should be started, stopped or changed on the basis of a lab value, and a licensed provider evaluates whether any change is appropriate.
The third factor is the assay itself. Macroprolactin, the large and largely inactive complexed form, is detected by many immunoassays and can produce a raised result in someone with no clinical features at all, which is why laboratories often screen for it before further investigation[2]. Recognising macroprolactinaemia has been described as a way to avoid unnecessary imaging and follow-up[12]. Pregnancy, breastfeeding, thyroid status and kidney function round out the list of things that legitimately move the number.
Habits sit at the gentler end of the spectrum. Sleep quality, training load, chronic psychological stress and alcohol intake are all plausibly connected to where a result lands on a given morning, though their influence is usually smaller than medication or sampling effects. The practical takeaway is to standardise the conditions and retest rather than to chase a single reading.
Prolactin is measured from a venous blood sample as part of FitScript's hormone panel, alongside the gonadotropins, sex hormones and thyroid markers that give the value its context. The membership covers 150+ biomarkers tested per year, so a single reading becomes part of a tracked series rather than a one-off snapshot.
Atlas, FitScript's AI health advisor, reads the result in context, against the standard reference range, against the optimal range, and against the other markers drawn at the same time. That interpretation becomes part of your FitScript, the personalised output built from your own biology, which flags patterns worth watching and questions worth raising.
Where a result suggests something beyond lifestyle and sampling conditions, the next step belongs with a clinician. Any prescription option, and any imaging or specialist referral, is evaluated by a licensed provider who reviews your history, symptoms and full panel before deciding whether it is appropriate. This page is educational and is not medical advice.
Prolactin is close to uninterpretable in isolation, so it is read as part of a group. Luteinizing Hormone and FSH show whether the pituitary signal to the gonads is intact or suppressed, which is the first question a raised prolactin raises. Testosterone Total and Testosterone Free show the downstream result of that signal in men and are often the markers where a hormonal effect first becomes visible. Estradiol plays the equivalent role in women and also feeds back on prolactin secretion itself. TSH matters because an underactive thyroid is a recognised and readily identified contributor to a raised reading. All of these sit together on FitScript's Hormone Panel for men and Hormone Panel for women.
Prolactin is a pituitary hormone with a job far broader than lactation, and its level is unusually sensitive to when and how the blood is drawn. Typical adult reference ranges run around 2 to 25 ng/mL, with FitScript's optimal range at 2 to 15 ng/mL for adults generally and 2 to 25 ng/mL for women. A single raised value is common and often explained by timing, stress, a medication or macroprolactin. A persistently raised value, particularly with low LH, low FSH or low sex hormones, is the pattern that warrants a proper workup. Discuss your results and any treatment options with a clinician or licensed provider rather than acting on a number alone.
Most laboratories regard roughly 2 to 25 ng/mL as the typical adult reference range, though the exact figures depend on the lab, the assay and the units used. FitScript's optimal range is 2 to 15 ng/mL for adults generally and 2 to 25 ng/mL for women, and those optimal figures are optimisation targets rather than diagnostic cut-offs. Always compare your result with the range printed on your own report.
Usually not. The hormone rises with sleep, stress, exercise, sexual activity and nipple stimulation, and even the discomfort of the blood draw can lift it. Standard practice is to confirm a raised value with a repeat sample taken under calm, standardised conditions before investigating further. A markedly high result, or one with headaches or vision changes, is worth discussing with a clinician promptly.
Levels peak during sleep and in the hours after waking, then decline across the morning, so a mid-morning draw after you have been awake and settled for a while is the usual compromise. Avoiding intense exercise, sexual activity and nipple or chest wall stimulation beforehand helps keep the reading representative.
Acute physical and psychological stress is associated with a short-term rise, and the stress of venepuncture itself is one recognised reason for a mildly elevated reading. This is one of several reasons a single raised value is treated as a starting point rather than a conclusion.
Macroprolactin is a large, complexed and largely inactive form of the hormone that many immunoassays still detect. It can produce an elevated result in someone with no symptoms at all, which is why laboratories often screen for it before recommending imaging or further workup. Recognising it helps avoid unnecessary investigation.
A sustained elevation dampens the pulsed hypothalamic signal that drives LH and FSH, and because LH is what prompts testosterone production, testosterone can fall as a result. That is why total testosterone, free testosterone, LH and FSH are usually read alongside prolactin rather than separately.
Yes. In men, raised levels are associated with reduced libido, erectile difficulty, fatigue, reduced fertility and, over time, lower testosterone and reduced bone density. Because the early symptoms are vague, elevations in men are often picked up incidentally on a hormone panel.
On its own, rarely. There is no meaningful lower limit of concern for most adults outside the postpartum period, where deficiency can affect milk supply. A low value matters more when it appears alongside other low pituitary outputs such as LH, FSH or TSH, since that combination points toward broader pituitary function and is worth reviewing with a clinician.